Physician

Amit Patel, M.D.

According to 2025 Medicare claims, Amit Patel, M.D. (NPI: 1861750028) practices anesthesiology in the Chattanooga, TN-GA market, with the plurality of this provider's patient population coming from Walker, GA. This provider's primary affiliated billing organization is GEORGIA PAIN AND WELLNESS CENTER (NPI: 1356781181; TIN: 462591194) and primary practice location at 30720-8394.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 331 traditional Medicare patients, billed 2,476 HCPCS/CPT codes, and received $165,044 in Medicare payments. The top billing code was G0481 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 10,530 prescription claims across 1,098 beneficiaries totaling $996,273 in drug costs, led by Belbuca (Buprenorphine Hcl). 2018 DME data shows 30 claims. Open Payments data shows 65 records totaling $2,066. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $551,937 to $165,044. In contrast, Part D prescription costs have risen steadily, from $14,272 to $996,273. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	835	13,589	$551,937
2018	1,124	18,358	$952,574
2019	1,078	4,443	$246,951
2020	276	2,349	$178,004
2021	260	2,711	$217,891
2022	344	3,883	$283,425
2023	318	2,972	$217,042
2024	331	2,476	$165,044

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	71	146	$14,272
2017	766	6,670	$434,031
2018	1,014	20,953	$1,216,447
2019	1,279	6,461	$430,762
2020	520	4,334	$266,857
2021	560	7,437	$829,490
2022	886	11,722	$1,258,779
2023	1,006	10,865	$1,353,273
2024	1,098	10,530	$996,273

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	27	28	$14,447
2018	11	30	$1,703
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	73	82	$151
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	131	168	$111
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	178	319	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	263	941	$56
80305	Testing for presence of drug, read by direct observation	200	344	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Belbuca	Buprenorphine Hcl	425	12,478	$314,455
Relistor	Methylnaltrexone Bromide	78	2,428	$196,012
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	2,052	57,651	$134,445
Buprenorphine	Buprenorphine	336	9,379	$92,471
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	2,201	61,349	$55,069

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	65	$2,066	Nalu Medical, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amit Patel, M.D.?

Tedicare shows public-source Medicare data for Amit Patel, M.D. (NPI 1861750028), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amit Patel, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Amit Patel, M.D.?

Amit Patel, M.D. is linked to GEORGIA PAIN AND WELLNESS CENTER (billing NPI 1356781181) in the available physician profile data.

Does Amit Patel, M.D. have Open Payments data?

Amit Patel, M.D. has 65 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.